Form N-CEN - Annual Report for Registered Investment Companies:
SEC Accession No. 0001752724-24-283803
Filing Date
2024-12-16
Accepted
2024-12-16 11:48:20
Documents
5
Period of Report
2024-09-30
Effectiveness Date
2024-12-16

Document Format Files

Seq Description Document Type Size
1 primary_doc.html N-CEN  
1 primary_doc.xml N-CEN 28090
2 NCEN_811-06565_13453533_0924.htm MATERIAL AMENDMENTS 13798
3 NCEN_811-06565_18338061_0924.htm ITEM 405 REG S-K 2391
4 NCEN_811-06565_84958532_0924.htm INTERNAL CONTROL RPT 12586
5 NCEN_811-06565_91299306_0924.htm ADVISORY CONTRACTS 69570
  Complete submission text file 0001752724-24-283803.txt   127767
Mailing Address 1900 MARKET STREET SUITE 200 PHILADELPHIA PA 19103
Business Address 1900 MARKET STREET SUITE 200 PHILADELPHIA PA 19103 6177728515
abrdn Life Sciences Investors (Filer) CIK: 0000884121 (see all company filings)

EIN.: 043147016 | State of Incorp.: MA | Fiscal Year End: 0930
Type: N-CEN | Act: 40 | File No.: 811-06565 | Film No.: 241550795